Trial Profile
Efficacy of human papillomavirus vaccine in subjects with bone marrow failure syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics
- 27 Apr 2015 New trial record